Research suggests booster doses may be necessary for monkeypox immunity

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)...

MRI-guided SBRT reduces side effects in prostate cancer treatment

Findings After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body...

Fertility warning: SARS-CoV-2 can linger in sperm for months after infection

Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that SARS-CoV-2,...

Doxycycline increases antimicrobial resistance in the gut without disrupting microbiome diversity

New research reveals that doxycycline post-exposure prophylaxis raises resistance gene levels in the gut, but leaves the overall...

Healthcare workers unprepared for mpox outbreak due to knowledge gaps and vaccine inequity

Study: International healthcare workers’ experiences and perceptions of the 2022 multi-country mpox outbreak. Image Credit: Corona Borealis Studio / Shutterstock...

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

In a recent study published in The Lancet Infectious Diseases, researchers elucidated monkeypox's (mpox) epidemiological and clinical features...

New $39 million government funding to improve access to HIV treatment

People without Medicare can now access government-funded HIV treatment, after a $39 million investment from the federal government....

Exploring sexual health challenges in women with pelvic floor disorders

Many women experience problems due to a weakened or damaged pelvic floor. These ailments are most common in...

Gonorrhea cases surge 64% post-COVID lockdown in England, highlighting unintended STI suppression

In a recent study published in the journal Emerging Infectious Diseases, researchers analyzed data from the Genitourinary Medicine...

Survey highlights inadequate sexual health education for LGBTQ+ adolescents

Children across the United States who identify as LGBTQ+ say the sexual health education curricula they receive is...

Generational differences in men’s health habits and concerns revealed

A new national survey by Cleveland Clinic revealed similarities and differences across generations when it comes to men's...

New STI impacts 1 in 3 women: Landmark study reveals men are the missing link

A landmark study reveals that bacterial vaginosis (BV), a condition affecting nearly a third of women worldwide and...

New survey highlights gaps in menopause knowledge and management

The Kinsey Institute at Indiana University, in partnership with leading sexual wellbeing company the Lovehoney Group and its...

Study highlights advantages of syphilis self-testing: convenience, privacy, and rapid results

In a recent study published in The Lancet Public Health, researchers performed a meta-analysis on the utility of...

Mount Sinai leads the way with first HYDROS Robotic System procedure in New York City

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS™ Robotic System, a cutting-edge...

Study establishes a national benchmark for cancer survivorship care

With the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the...

Gonorrhoea surge in England following COVID-19 restrictions lift

In a recent study posted to the medRxiv* preprint server, a group of researchers analyzed the rise in...

Understanding the impact of weight loss medications on female reproductive health

In recent months, the efficacy of contraception for people taking weight loss medications has been questioned, as several women...

Surge in syphilis cases leads some providers to ration penicillin

When Stephen Miller left his primary care practice to work in public health a little under two years...

Sexually transmitted infections pose new threat to aging adults

The incidence of HIV and other STIs among people aged 60 to 89 years is increasing in some...

ChatGPT could be an effective tool to help reduce vaccine hesitancy

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) suggests that the free-to-use, widely accessible ChatGPT could be an effective tool to help reduce vaccine hesitancy among the general public, as well as providing helpful advice on sexually transmitted infections (STIs) in conjunction with sexual health clinics, by improving knowledge and access to care.

Our findings showed that ChatGPT displayed a remarkable ability to accurately respond to a wide breadth of commonly asked questions, encompassing topics such as misconceptions around mRNA vaccination and the importance of testing for STIs. In the majority of instances, ChatGPT performed at the level of advice provided by professional organizations and guidelines."

Dr Matthew Koh,lead author from the National University Health System (NUHS) in Singapore

Since its unveiling in November 2022, millions of people have used AI (artificial intelligence) chatbots like ChatGPT for everything from making music to answering trivia to helping with homework. But ChatGPT has been mired in issues around its accuracy.

Vaccines have stopped epidemics and almost eradicated deadly diseases in the past such as polio, but vaccine hesitancy, directly linked to misinformation – false, inaccurate information promoted as factual – is on the rise, resulting in lower vaccine uptake. Since the public debut of ChatGPT, individuals with mistrust of health professionals may be using the technology to address their concerns.

Similarly, for individuals trying to access information on sexual health, or those worried about the stigma and embarrassment of attending a clinic, or with limited access to healthcare, could find using ChatGPT is a good way to get answers about STIs.

To find out more, researchers from the NUHS in Singapore tested ChatGPT to see whether it could successfully provide answers to common questions about vaccination and STIs.

A team of physicians who run infectious disease clinics asked ChatGPT to answer 15 commonly asked questions on vaccine hesitancy, including questions on doubts about the efficacy of vaccines, concerns about adverse effects, and cultural concerns relating to vaccines (see table in notes to editors).

They also asked ChatGPT 17 common questions on STIs based on general risk factors, access to care and diagnosis, and management and post-exposure prophylaxis (see table in notes to editors).

The AI-generated responses on vaccine hesitancy were then assessed by two independent infectious disease experts against recommendations from the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), and the chatbot answers on STIs were assessed against the 2021 US CDC STI Treatment Guidelines. All responses were evaluated for their completeness, quality, and accuracy.

Factual responses to vaccine hesitancy concerns

The researchers found that overall ChatGPT's output provided factual responses and reassurance to vaccine hesitancy concerns.

For example, ChatGPT accurately highlighted the indication for measles vaccination in low incidence settings, and discussed the potential benefits of male human papillomavirus (HPV) vaccination. However, the AI chatbot failed to acknowledge the suggested ACIP age cut-offs for HPV vaccination, or account for a specific individual's situation such as how sexually active they are.

In addition, ChatGPT provided reassurances for people with an egg allergy and influenza vaccination, and addressed misconceptions around mRNA vaccination and permanent alterations in DNA with high accuracy. However, it did not offer the non-mRNA vaccine options for COVID-19, but did encourage further discussions with healthcare professionals.

ChatGPT also appropriately acknowledged the complexity of religious issues around vaccination and directed individuals to have further discussions with religious leaders. Importantly, however, the researchers found that without specific details of the religious concern and the specific vaccine, ChatGPT's advice was generic and it did not provide a more detailed risk-benefit discussion.

"Overall, ChatGPT's responses to vaccine hesitancy were accurate and may help individuals who have vaccine-related misconceptions", says Dr Koh, who is also an infectious diseases physician at the National University Hospital in Singapore. "Our results demonstrate the potential power of AI models to assist in public health campaigns and aid health professionals in reducing vaccine hesitancy."

STI responses generally accurate and concise

The researchers also found that overall, ChatGPT's responses on STIs were mostly accurate and concise.

For example, when asked about how to prevent STIs, the chatbot recommended safe sex practices HPV vaccinations as well as abstinence, but it failed to provide guidance on other key elements such as HIV pre-exposure prophylaxis.

In addition, the AI chatbot was able to provide general reassurance about STI symptoms, such as noting that other possibilities exist, and recommended going for testing. It also consistently communicated the importance of partner testing and follow-up testing.

However, when asked about chlamydia treatment, ChatGPT suggested either azithromycin or doxycycline, although the CDC favors doxycycline as the first-line treatment. It also failed to highlight the importance of testing for other STIs.

"ChatGPT provided good general advice about STIs, but it lacked specificity and could not tailor its advice to individual's risk of acquiring STIs", says Dr Koh. "The goal of this project is to empower the general public. The hope is that individuals can educate themselves with ChatGPT by making accurate advice more accessible and increase vaccine uptake and protection from STIs."

He continues "We believe that ChatGPT should be used in conjunction with, or in addition to, a physician consultation – the human response is still needed to contextualize the advice that is given to a specific individual's situation and for it to make the most sense and be the most helpful for the patient."

Sources:
  • ESCMID Global Congress
  • European Society of Clinical Microbiology and Infectious Diseases


Source: http://www.news-medical.net/news/20240410/ChatGPT-could-be-an-effective-tool-to-help-reduce-vaccine-hesitancy.aspx

Inline Feedbacks
View all comments
guest